MIRIKIZUMAB-INDUCED TRANSCRIPTOME CHANGES IN PATIENT BIOPSIES AT WEEK 12 ARE MAINTAINED THROUGH WEEK 52 IN PATIENTS WITH ULCERATIVE COLITIS

Travis Johnson  ¹     Boyd Steere  ²     Pengyue Zhang  ²     Yong Zang  ²     Richard Higgs  ²     Klaus Gottlieb  ²     Walter Reinisch  ³     Julian Panés  ⁴     Venkatesh Krishnan  ^4    
1 Indiana University Clinical and Translational Sciences Institute (CTSI), Indianapolis, United States
² Eli Lilly and Company, Indianapolis, United States
³ Medical University of Vienna, Vienna, Austria
⁴ Hospital Clinic of Barcelona, Barcelona, Spain

Session
IBD: Clinical trials poster I

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)